Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels

被引:18
|
作者
Pischon, Tobias
Moehlig, Matthias
Hoffmann, Kurt
Spranger, Joachim
Weikert, Cornelia
Willich, Stefan N.
Pfeiffer, Andreas F. H.
Boeing, Heiner
机构
[1] German Inst Human Nutr DlfE, Dept Epidemiol, Potsdam Rehbruecke, D-14558 Nuthetal, Germany
[2] Charite, Med Ctr, Inst Social Med, Epidemiol & Hlth Econ, Berlin, Germany
[3] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany
[4] Charite Univ Med Ctr, Dept Endocrinol Diabet & Nutr, Berlin, Germany
关键词
competing risk; epidemiology; myocardial infarction; population attributable fraction; risk factors; stroke;
D O I
10.1007/s10654-007-9141-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
C-reactive protein (CRP) was proposed as a stronger predictor of cardiovascular events than low-density lipoprotein cholesterol (LDL-C); however, these associations may differ between myocardial infarction (MI) and stroke. We compared statistically the associations of CRP and LDL-C levels with risk of MI versus stroke and examined to what extent consideration of CRP or LDL-C increases the population attributable fractions (PAFs) of MI and stroke beyond traditional risk factors among 27,548 subjects from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study in a case-cohort design. Among subjects without prior MI or stroke, 156 developed MI and 132 stroke during 6.0 years of follow-up. In adjusted competing risk analyses CRP was positively related to MI and stroke (P difference between endpoints = 0.55), whereas LDL-C was related to MI but not stroke (P difference between endpoints = 0.003). The PAF for smoking, diabetes, and hypertension combined was 0.76 for MI, and 0.58 for stroke. With additional consideration of CRP the PAFs were 0.80 and 0.68, while with addition of LDL-C the PAFs were 0.88 and 0.55. We conclude that CRP is equally strongly related to risk of MI and stroke, whereas LDL-C is related to risk of MI but not stroke. Consideration of LDL-C beyond smoking, diabetes and hypertension may increase the PAF of MI slightly more than CRP. In contrast, consideration of CRP but not of LDL-C may increase the PAF of stroke beyond these factors.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [1] Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels
    Tobias Pischon
    Matthias Möhlig
    Kurt Hoffmann
    Joachim Spranger
    Cornelia Weikert
    Stefan N. Willich
    Andreas F. H. Pfeiffer
    Heiner Boeing
    European Journal of Epidemiology, 2007, 22 : 429 - 438
  • [2] Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker, PM
    Rifai, N
    Rose, L
    Buring, JE
    Cook, NR
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20): : 1557 - 1565
  • [3] Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the presence and degree of carotid stenosis
    Mullenix, PS
    Steele, S
    Martin, M
    Starnes, B
    Andersen, C
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S105 - S105
  • [4] Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk
    Herrmann, W
    Obeid, R
    Hübner, U
    Jouma, M
    Geisel, J
    CELLULAR AND MOLECULAR BIOLOGY, 2004, 50 (08) : 895 - 901
  • [5] C-reactive protein and low density lipoprotein as predictive marker for myocardial infarction
    Shaikh, Farheen
    Shaikh, Shakeel Ahmed
    Memon, Ali Raza
    Khan, Abdul Sattar
    Surahio, Ateeq Ur Rahman
    Bhatti, Muhammad Ishaque
    RAWAL MEDICAL JOURNAL, 2021, 46 (04): : 810 - 812
  • [6] Effect of withdrawal of Pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol
    van der Harst, Pim
    Asselbergs, Folkert W.
    Hillege, Hans L.
    Bakker, Stephan J. L.
    Voors, Adriaan A.
    van Veldhuisen, Dirk J.
    van Gilst, Wiek H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (10): : 1548 - 1551
  • [7] Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women
    Dotevall, A
    Hulthe, J
    Rosengren, A
    Wiklund, O
    Wilhelmsen, L
    CLINICAL SCIENCE, 2001, 101 (05) : 523 - 531
  • [8] THE INTERACTION OF VERY LOW-DENSITY LIPOPROTEIN AND LOW-DENSITY LIPOPROTEIN WITH RABBIT AND RAT C-REACTIVE PROTEIN
    ROWE, IF
    SOUTAR, AK
    TRAYNER, I
    BALTZ, ML
    DEBEER, FC
    WALKER, L
    BOWYER, D
    PEPYS, MB
    CLINICAL SCIENCE, 1983, 65 (03) : P30 - P30
  • [9] LOW-DENSITY LIPOPROTEIN AND VERY LOW-DENSITY LIPOPROTEIN ARE SELECTIVELY BOUND BY AGGREGATED C-REACTIVE PROTEIN
    DEBEER, FC
    SOUTAR, AK
    BALTZ, ML
    TRAYNER, IM
    FEINSTEIN, A
    PEPYS, MB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (01): : 230 - 242
  • [10] Comparison of effects, of Ezetimibe/Simvastatin versus Simvastatin versus Atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels
    Pearson, Thomas
    Ballantyne, Christie
    Sisk, Christine
    Shah, Arvind
    Veltri, Enrico
    Maccubbin, Darbie
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12): : 1706 - 1713